Anzeige
Mehr »
Dienstag, 03.06.2025 - Börsentäglich über 12.000 News
Gestern Kursverdopplung durch Uran-Hoffnung - zündet jetzt der nächste Vervielfacher?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DK8U | ISIN: LU2458332611 | Ticker-Symbol: Z45
Frankfurt
03.06.25 | 15:29
9,640 Euro
-2,82 % -0,280
1-Jahres-Chart
ALVOTECH Chart 1 Jahr
5-Tage-Chart
ALVOTECH 5-Tage-Chart
RealtimeGeldBriefZeit
9,92010,20017:26

Aktuelle News zur ALVOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrAlvotech and Advanz to commercialise biosimilars in Europe3
MiAlvotech and Advanz Pharma add three more biosimilars to collaboration4
MiAlvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Three Additional Biosimilars in Europe345Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programsThe agreement includes proposed biosimilars...
► Artikel lesen
27.05.Alvotech - 6-K, Report of foreign issuer13
ALVOTECH Aktie jetzt für 0€ handeln
26.05.Alvotech Annual General Meeting to be held June 25, 20254
23.05.Alvotech: Transactions of Managers and Closely Associated Persons4
19.05.Alvotech Appoints DNB Carnegie as Liquidity Provider on Nasdaq Stockholm3
19.05.Trading in Alvotech's Shares on Nasdaq Stockholm Commences Today5
19.05.Nasdaq Stockholm Welcomes Alvotech to the Main Market204Stockholm/Reykjavík, 19 May 2025 - Nasdaq (Nasdaq: NDAQ) announces that trading in the Swedish Depository Receipts (SDRs), equity share equivalents, of Alvotech (ticker: ALVO SDB) will commence today...
► Artikel lesen
16.05.Alvotech Announces the Outcome of the Offering in Connection with the Company's Listing on Nasdaq Stockholm751Not to be released, published, distributed or circulated in any jurisdiction in which it would be unlawful to do so. This press release is for information purposes only and does not constitute an...
► Artikel lesen
16.05.Listing of Alvotech on Nasdaq Stockholm461On request of Alvotech, company registration number B258884, Nasdaq Stockholm has admitted the company's SDRs to trading with effect from 19 May 2025. The decision is conditional upon that Alvotech...
► Artikel lesen
16.05.Alvotech: Transactions of Managers and Closely Associated Persons2
09.05.Alvotech: Transactions of Managers and Closely Associated Persons8
08.05.Alvotech Publishes Prospectus in Connection with its Listing on Nasdaq Stockholm513Not to be released, published, distributed or circulated in the United States or any other jurisdiction in which it would be unlawful to do so. This press release is for information purposes only and...
► Artikel lesen
08.05.Alvotech GAAP EPS of $0.39, revenue of $132.8M beats by $37.78M17
07.05.Alvotech Reports Results for the First Quarter of 2025 and Provides Business Update433Total Revenues in the first quarter of 2025 reached $132.8 million, compared to $36.9 million in the same period last year, representing a 260% increaseProduct Revenues in the first in the first quarter...
► Artikel lesen
07.05.Alvotech sees minimal impact on 2025 product revenues from tariffs16
07.05.Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech's Product Revenues in 2025289REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the "Company") a global biotech company specializing in the development and manufacture of biosimilar medicines for patients...
► Artikel lesen
05.05.Teva, Alvotech get FDA nod for Johnson & Johnson biosimilar29
05.05.Teva Pharm und Alvotech-Aktien steigen nach FDA-Zulassung von SELARSDI18
Seite:  Weiter >>
77 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1